PMGC HOLDINGS INC. Net Income (Loss) Allocated to Limited Partners
PMGC HOLDINGS INC. (ELAB) reported Net Income (Loss) Allocated to Limited Partners of $4.30 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NetIncomeLossAllocatedToLimitedPartners · last filed 2024-03-29
- PMGC HOLDINGS INC. net income (loss) allocated to limited partners for the quarter ending 2023-12-31 was -$3.14B.
- PMGC HOLDINGS INC. net income (loss) allocated to limited partners for the quarter ending 2022-12-31 was -$1.15B.
- PMGC HOLDINGS INC. net income (loss) allocated to limited partners for fiscal 2023 was $4.30M, a 138.94% increase from fiscal 2022.
- PMGC HOLDINGS INC. net income (loss) allocated to limited partners for fiscal 2022 was $1.80M.
| Period end | Net Income (Loss) Allocated to Limited Partners 3 month | Net Income (Loss) Allocated to Limited Partners 9 month | Net Income (Loss) Allocated to Limited Partners 12 month |
|---|---|---|---|
| 2023-12-31 | -$3.14B derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $4.30M 10-K · filed 2024-03-29 | |
| 2023-09-30 | $3.14B 10-Q · filed 2023-12-11 | ||
| 2022-12-31 | -$1.15B derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.80M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $1.15B 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |